Key result
Various antiarrhythmic drugs and selective benzyloxyphenyl analogues inhibit the Na+/Ca2+ exchanger, acting either from the cytosolic side or from extracellular/intramembrane sites.
Answers are grounded in this paper and cite their sources.
Pharmacological characterization reveals that several antiarrhythmic drugs and selective inhibitors block the Na+/Ca2+ exchanger via distinct binding sites, supporting the addition of NCX to the Sicilian Gambit classification of antiarrhythmic drugs.
Using the whole-cell voltage clamp, we examined acute effects of various agents on Na(+)/Ca(2+) exchange current (I(NCX)) in guinea-pig cardiac ventricular cells and transfected cells. Among the antiarrhythmic drugs, amiodarone, bepridil, dronedarone, cibenzoline, azimilide, and aprindine inhibited I(NCX) in a concentration-dependent manner. We also investigated the effects on NCX of 2,3-buanedione monoxim (BDM) and selective NCX inhibitors such as KB-R7943, SEA0400, and SN-6. The presence of trypsin in the pipette solution attenuated the inhibitory effects on NCX of amiodarone, bepridil, and BDM, suggesting that these drugs inhibit NCX from the cytosolic side. In contrast, the trypsin-insensitive NCX inhibitors were aprindine, azimilide, dronedarone, cibenzoline, KB-R7943, SEA0400, and SN-6. KB-R7943, SEA0400, and SN-6 suppressed the uni-directional outward I(NCX) more potently than the uni-directional inward I(NCX). The mechanism of this mode-dependency is unknown, but is suggested to be related to intracellular Na(+) concentration.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2006) reported a review. Na+/Ca2+ Exchanger Inhibitors was evaluated. Various antiarrhythmic drugs and selective benzyloxyphenyl analogues inhibit the Na+/Ca2+ exchanger, acting either from the cytosolic side or from extracellular/intramembrane sites.
Synapse has enriched 10 related papers. Consider them for comparative context: